Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway.
Rahmani F, Hashemzehi M, Avan A, Barneh F, Asgharzadeh F, Moradi Marjaneh R, Soleimani A, Parizadeh M, Ferns GA, Ghayour Mobarhan M, Ryzhikov M, Afshari AR, Ahmadian MR, Giovannetti E, Jafari M, Khazaei M, Hassanian SM.
Rahmani F, et al. Among authors: parizadeh m.
Cell Signal. 2021 Sep;85:110069. doi: 10.1016/j.cellsig.2021.110069. Epub 2021 Jun 29.
Cell Signal. 2021.
PMID: 34214591